Project Grant HT94252510755
Award Date
8/1/25
Completion Date
7/31/26
Dollars Obligated
$487K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
East Cambridge, MA 02141, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,000,000.00 in funding to Tekhona Inc., a for-profit S corporation, to develop intra-articular immunoregulatory microparticles for inducing systemic remission in rheumatoid arthritis. The 2-year research project, with an award date of September 15, 2023 and an ultimate completion date of September 14, 2025, aims to transform healthcare for Service...
The Defense Health Agency awarded a $5,339,958 Project Grant to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a digital health intervention for self-management and telemonitoring in chimeric antigen receptor (CAR)-T cell therapy. This 4-year research project, running from June 2025 to June 2029, aims to advance medical solutions for the battlefield and transform healthcare for...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,070,414.00 to the University of Miami to conduct research on mesenchymal stem cell extracellular vesicle therapies for epidermolysis bullosa. The research, which will take place in South Miami, FL from May 1, 2025 to April 30, 2028, aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
The Defense Health Agency awarded a $997,343 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis. The research aims to transform healthcare for military service members and the broader public through innovative and impactful biomedical investigations spanning basic, applied, and translational research. The award period runs from...
The Department of Defense's Defense Health Agency has awarded a $4,876,076 Project Grant to Washington University to develop a novel point-of-care multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome and sepsis. This research falls under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The grant has a performance...